Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crossover comparison of testosterone serum levels with Testopatch versus Pantestone in hypogonadal men
2004-004891-36Phase 3Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of testosterone in Hypogonadism (2 arms), sponsored by Pierre Fabre Laboratories. Primary endpoint: Average total testosterone serum level over the last 48 hours of each treatment period. Started Nov 2005; status: completed.
02
Drugs
testosterone
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on 2004-004891-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004891-36.